A

Armistice Capital LLC

25 employees

Armistice Capital is a global, value-oriented and event-driven hedge fund focused primarily on the health care and consumer sector.

Investor insights

Sectors invested in

Biotechnology10
Health Care8
Pharmaceutical7
Medical4
Therapeutics3
Biopharma2
Wellness2
Medical Device2
Ophthalmology2
healthcare2
glioblastoma1
Life Science1
Personal Health1
presbyopia1
technology1
mydriasis1
optometry1
innovation1
Clinical-stage1
Oncology1

Funding rounds participated in

$26M sweet spot round size

Most of their 12 investments are in rounds between $11M and $54M

Investor type

Hedge Fund

Basic info

Industry

financial services

Date founded

2012

Investments made

U

Undisclosed raised $22M on August 24, 2023

Investors: Armistice Capital LLC

C

COMPASS Pathways raised $125M on August 16, 2023

Investors: Vivo Capital, Soleus Capital Management, L.P., Laurion Capital Management LP, Partner Fund Management, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, TCG X and Armistice Capital LLC

L

Lyra Therapeutics raised $50M on May 26, 2023

Investors: Woodline Partners LP, Samsara BioCapital, Surveyor Capital, Perceptive Advisors and Armistice Capital LLC

S

Spruce Biosciences raised $54M on February 9, 2023

Investors: RiverVest Venture Partners, Abingworth, 5AM Ventures, Novo Holdings, HealthCap and Armistice Capital LLC

K

Karyopharm Therapeutics Inc. raised $165M on December 5, 2022

Investors: Adage Capital Management, HEALTHCOR LTD, Surveyor Capital, Marshall Wace, Avidity Partners and Armistice Capital LLC

P

Provention Bio raised $60M on July 7, 2022

Investors: Armistice Capital LLC

E

Eyenovia Inc. raised $15M on March 4, 2022

Investors: Armistice Capital LLC

X

Xeris Pharmaceuticals, Inc. raised $30M on January 3, 2022

Investors: Armistice Capital LLC

E

ERYTECH Pharma raised $7.9M on December 13, 2021

Investors: Armistice Capital LLC

M

Mauna Kea Technologies raised $15M on September 24, 2021

Investors: Armistice Capital LLC

FAQ